IC is a severe and life-threatening form of Candida infection
IC is a severe and life-threatening form of Candida infection
Study suggests that palbociclib could be used to treat around a fifth of people with TNBC
The New Variant Assessment Platform will be led by Public Health England
Neutralising antibodies significantly reduced COVID-19-related hospitalisations and deaths
Study also discovered a rapid change in practise for breast cancer treatments
First checkpoint inhibitor to be approved in the EU to treat MSI-H or dMMR colorectal cancer
System will allow ‘in vitro diagnostics devices a faster and easier route to market’
Cost-effectiveness agency initially turned down the drug in this setting
Biopharma company has raised approximately £33m to date
Bispecific antibody met non-inferiority measure compared to Regeneron’s Eylea
Oral JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis
Lab tests evaluated vaccine’s efficacy against UK and South African variants
The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be conducted virtually.
BTK inhibitor demonstrated non-inferior progression-free survival compared to Imbruvica
Over 30 new vaccination centres open across England